Advertisement
NSRX vs OGN
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NSRX is a Hold and OGN is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
NSRX’s FA Score shows that 0 FA rating(s) are green whileOGN’s FA Score has 2 green FA rating(s).
- NSRX’s FA Score: 0 green, 5 red.
- OGN’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
NSRX’s TA Score shows that 6 TA indicator(s) are bullish while OGN’s TA Score has 4 bullish TA indicator(s).
- NSRX’s TA Score: 6 bullish, 4 bearish.
- OGN’s TA Score: 4 bullish, 4 bearish.
Price Growth
NSRX (@Pharmaceuticals: Major) experienced а +10.50% price change this week, while OGN (@Pharmaceuticals: Major) price change was +0.22% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +3.46%. For the same industry, the average monthly price growth was +4.50%, and the average quarterly price growth was +4.64%.
Reported Earning Dates
NSRX is expected to report earnings on Sep 02, 2026.
OGN is expected to report earnings on Aug 24, 2026.
Industries' Descriptions
@Pharmaceuticals: Major (+3.46% weekly)The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.
| NSRX | OGN | NSRX / OGN | |
| Capitalization | 46.8M | 3.61B | 1% |
| EBITDA | N/A | 1.31B | - |
| Gain YTD | -56.284 | 92.815 | -61% |
| P/E Ratio | N/A | 17.63 | - |
| Revenue | N/A | 6.13B | - |
| Total Cash | N/A | N/A | - |
| Total Debt | N/A | 8.55B | - |
| NSRX | OGN | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 90% | 3 days ago 66% |
| Stochastic ODDS (%) | 3 days ago 90% | 3 days ago 66% |
| Momentum ODDS (%) | 3 days ago 86% | 3 days ago 74% |
| MACD ODDS (%) | 3 days ago 82% | 3 days ago 74% |
| TrendWeek ODDS (%) | 3 days ago 82% | 3 days ago 64% |
| TrendMonth ODDS (%) | 3 days ago 84% | 3 days ago 58% |
| Advances ODDS (%) | 3 days ago 86% | 3 days ago 66% |
| Declines ODDS (%) | 11 days ago 88% | 6 days ago 75% |
| BollingerBands ODDS (%) | 3 days ago 90% | 3 days ago 70% |
| Aroon ODDS (%) | 3 days ago 90% | 3 days ago 42% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| BRXRX | 20.19 | 0.25 | +1.25% |
| MFS Blended Research Intl Eq R1 | |||
| VDMRX | 11.53 | 0.09 | +0.79% |
| Virtus KAR Developing Markets R6 | |||
| ASCRX | 20.16 | 0.15 | +0.75% |
| American Century Small Company R | |||
| PXEAX | 24.32 | 0.16 | +0.66% |
| Impax Global Environmental Markets A | |||
| MIOPX | 33.16 | 0.19 | +0.58% |
| Morgan Stanley Inst International Opp A | |||
NSRX and
Correlation & Price change
A.I.dvisor tells us that NSRX and MDCX have been poorly correlated (+5% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NSRX and MDCX's prices will move in lockstep.
| Ticker / NAME | Correlation To NSRX | 1D Price Change % | ||
|---|---|---|---|---|
| NSRX | 100% | +3.90% | ||
| MDCX - NSRX | 5% Poorly correlated | -0.15% | ||
| OGN - NSRX | -4% Poorly correlated | +0.07% | ||
| ABBV - NSRX | -12% Poorly correlated | +1.20% |
OGN and
Correlation & Price change
A.I.dvisor tells us that OGN and AMGN have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OGN and AMGN's prices will move in lockstep.
| Ticker / NAME | Correlation To OGN | 1D Price Change % | ||
|---|---|---|---|---|
| OGN | 100% | +0.07% | ||
| AMGN - OGN | 22% Poorly correlated | +1.88% | ||
| BMY - OGN | 22% Poorly correlated | +2.35% | ||
| SNY - OGN | 21% Poorly correlated | +1.55% | ||
| BIIB - OGN | 21% Poorly correlated | +1.13% | ||
| GSK - OGN | 21% Poorly correlated | +0.87% | ||
More | ||||